HSF1 and neoplasm: Considering the intimate interaction between GBPs and HSP90 as well as the unleashing of HSP90-induced HSF1 without adjusting HSP90 animation, targeting GBPs appears to be an attractive and potent strategy to modify HSF1 for anti-tumor immunity treatment.